TY - JOUR
T1 - Monitoring nebulizer use in children
T2 - Comparison of electronic and asthma diary data
AU - Butz, Arlene M.
AU - Donithan, Michele
AU - Bollinger, Mary E.
AU - Rand, Cynthia
AU - Thompson, Richard E.
N1 - Funding Information:
* The Johns Hopkins University Schools of Medicine and Nursing, Baltimore, Maryland. † The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. ‡ The University of Maryland School of Medicine, Baltimore, Maryland. This research was supported by grant R01NR05060 from the National Institute of Nursing Research, National Institutes of Health. Received for publication August 9, 2004. Accepted for publication in revised form October 21, 2004.
PY - 2005/3/1
Y1 - 2005/3/1
N2 - Background: Measurement of nebulizer medication adherence that relies on self-report of medication use is subject to recall bias and increased patient burden. Electronic monitoring of nebulizer medication use is relatively new technology and provides an objective measure of nebulizer use. Objective: To examine levels of agreement for nebulizer use between self-report on diary cards and electronic monitor data in young inner-city children with asthma. Methods: Of 221 enrolled children with persistent asthma, 157 (71%) provided 12 weeks of diary card and nebulizer monitor recordings that were matched by date across days and by patient. Concordance, sensitivity, specificity, and κ coefficients were calculated between self-report and electronic data. Results: The children were predominantly African American (89%) and male (66%), with a mean age of 4.6 years. Their persistent asthma was categorized as mild (61%) or moderate to severe (35%). Concordance between diary and electronic data was 85%, with overreporting on diary cards noted on 15% of the total days. Sensitivity of the diary data relative to the electronic data ranged from 0.80 to 0.91 during the 12-week study. Diary return rates decreased from 75% during the initial 3 weeks to 44% at 12 weeks. Conclusions: Electronic monitoring of nebulizer use provides a more precise measure of long-term medication use than does self-report on diary cards, and it is feasible for use in high-risk populations. However, diary cards seem to be a valid alternative for short-term monitoring of nebulizer use, resulting in only a slight overestimation of medication use.
AB - Background: Measurement of nebulizer medication adherence that relies on self-report of medication use is subject to recall bias and increased patient burden. Electronic monitoring of nebulizer medication use is relatively new technology and provides an objective measure of nebulizer use. Objective: To examine levels of agreement for nebulizer use between self-report on diary cards and electronic monitor data in young inner-city children with asthma. Methods: Of 221 enrolled children with persistent asthma, 157 (71%) provided 12 weeks of diary card and nebulizer monitor recordings that were matched by date across days and by patient. Concordance, sensitivity, specificity, and κ coefficients were calculated between self-report and electronic data. Results: The children were predominantly African American (89%) and male (66%), with a mean age of 4.6 years. Their persistent asthma was categorized as mild (61%) or moderate to severe (35%). Concordance between diary and electronic data was 85%, with overreporting on diary cards noted on 15% of the total days. Sensitivity of the diary data relative to the electronic data ranged from 0.80 to 0.91 during the 12-week study. Diary return rates decreased from 75% during the initial 3 weeks to 44% at 12 weeks. Conclusions: Electronic monitoring of nebulizer use provides a more precise measure of long-term medication use than does self-report on diary cards, and it is feasible for use in high-risk populations. However, diary cards seem to be a valid alternative for short-term monitoring of nebulizer use, resulting in only a slight overestimation of medication use.
UR - http://www.scopus.com/inward/record.url?scp=15444365145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=15444365145&partnerID=8YFLogxK
U2 - 10.1016/S1081-1206(10)60988-X
DO - 10.1016/S1081-1206(10)60988-X
M3 - Article
C2 - 15801247
AN - SCOPUS:15444365145
SN - 1081-1206
VL - 94
SP - 360
EP - 365
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 3
ER -